Program
- Program 2023
Accreditation 2023
- Accreditation 2023
- COI Information
Exhibitors and Sponsors
- ADC 2023 Exhibitors
Program Organizers
Posters

Menu

Program
- Program 2023
Accreditation 2023
- Accreditation 2023
- COI Information
Exhibitors and Sponsors
- ADC 2023 Exhibitors
Program Organizers
Posters

Conversion of Cinacalcet to Etelcalcetide for Uncontrolled Hyperparathyroidism in Hemodialysis Patients – Abdullah Hamad, md

Annual Dialysis Conference > Posters > AdultP > Conversion of Cinacalcet to Etelcalcetide for Uncontrolled Hyperparathyroidism in Hemodialysis Patients – Abdullah Hamad, md

AdultP

January 13, 2022 By mimhav

1090 2022 Adult

Previous

Body Composition Monitor in Assessment of Nutritional Status in Hemodialysis Patients in a Tertiary Hospital - Sonja Escara, MD

Body Composition Monitor in Assessment of Nutritional Status in Hemodialysis Patients in a Tertiary Hospital - Sonja Escara, MD

Next

Serum Levels of Essential Elements Mg , Zn and Toxic Elements Pb ,Cd in Different Stages of CKD - MM Iqbal, MBBS

Serum Levels of Essential Elements Mg , Zn and Toxic Elements Pb ,Cd in Different Stages of CKD - MM Iqbal, MBBS

Presented in cooperation with

Contact

314-516-8419
Conferences@mimh.edu

Program
- Program 2023
Accreditation 2023
- Accreditation 2023
- COI Information
Exhibitors and Sponsors
- ADC 2023 Exhibitors
Program Organizers
Posters